HuGE Literature Finder
Records
1
-
30
| Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence. Neoplasma 2022 Jan . Wieczorek Edyta, Jablonowski Zbigniew, Lesicka Monika, Jablonska Ewa, Kutwin Piotr, Reszka Edyta, Garstka Malgorzata An |
| Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer. Scientific reports 2021 Oct 11 (1): 19596. Cho Su Han, Yoon Shinkyo, Lee Dae Ho, Kim Sang-We, Kim Kwone |
| The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis. Journal of orthopaedic surgery and research 2021 12 16 (1): 738. Zhang Chao, Wang Lin, Xiong Chuang, Zhao Runhan, Liang Hao, Luo Xiao |
| Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection. Cancers 2020 Dec 12 (12): . Miller Hannah, Czigany Zoltan, Lurje Isabella, Reichelt Sophie, Bednarsch Jan, Strnad Pavel, Trautwein Christian, Roderburg Christoph, Tacke Frank, Gaisa Nadine Therese, Knüchel-Clarke Ruth, Neumann Ulf Peter, Lurje Geo |
| Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy. BMC cancer 2019 May 19 (1): 483. Kim Yeon-Ji, Chung Woo Chul/, Jun Kyong-Hwa, Chin Hyung-M |
| The effect analysis of CYP2D6 gene polymorphism in the toremifene and tamoxifen treatment in patient with breast cancer. Pakistan journal of pharmaceutical sciences 2017 May 30 (3(Special)): 1095-1098. Zeng Yi, Huang Kai, Huang Weiw |
| KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Sullivan I, Salazar J, Arqueros C, Andrés M, Sebio A, Majem M, Szafranska J, Martínez E, Páez D, López-Pousa A, Baiget M, Barnadas |
| Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. Oncotarget 2017 Jan . Liu Fei, Luo Limei, Wei Yonggang, Wang Wentao, Wen Tianfu, Yang Jiayin, Xu Mingqing, Li |
| Analysis of Serum Cytokines and Single-Nucleotide Polymorphisms of SOD1, SOD2, and CAT in Erysipelas Patients. Journal of immunology research 2017 2017 2157247. Emene Charles C, Kravchenko Irina E, Aibatova Gulnaz I, Rizvanov Albert |
| Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. OncoTargets and therapy 2017 10 909-918. Tan Junyin, Jiang Li, Cheng Xiaowei, Wang Chunlin, Chen Jingshan, Huang Xiaoqing, Xie Peng, Xia Dongmei, Wang Rensheng, Zhang Yo |
| Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population. PloS one 2017 12 (8): e0183503. Ratnasari Neneng, Nurdjanah Siti, Sadewa Ahmad Hamim, Hakimi Mohammad, Yano Yoshihi |
| Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer. The Journal of clinical endocrinology and metabolism 2016 Nov jc20162555. Marotta Vincenzo, Sciammarella Concetta, Capasso Mario, Testori Alessandro, Pivonello Claudia, Chiofalo Maria Grazia, Gambardella Claudio, Grasso Marica, Antonino Antonio, Annunziata Annamaria, Macchia Paolo Emidio, Pivonello Rosario, Santini Luigi, Botti Gerardo, Losito Simona, Pezzullo Luciano, Colao Annamaria, Faggiano Antongiul |
| High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab. Surgery today 2016 Aug . Hara Masayasu, Nagasaki Takaya, Shiga Kazuyoshi, Takahashi Hiroki, Takeyama Hiromit |
| Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases. Autoimmunity 2016 Mar 1-7. Zaaber Ines, Rancier Marc, Stathopoulou Maria G, Saleh Abdelsalam, Marmouch Héla, Masson Christine, Murray Helena, Kurth Mary Jo, Lamont John, Fitzgerald Peter, Mahjoub Selvia, Said Khaled, Bel Hadj Jrad Tensaout Besma, Mestiri Souhir, Visvikis-Siest Soph |
| The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-ß1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent. PloS one 2016 11 (3): e0150500. Osadnik Tadeusz, Strzelczyk Joanna Katarzyna, Regu?a Rafa?, Bujak Kamil, Fronczek Martyna, Gonera Ma?gorzata, Gawlita Marcin, Wasilewski Jaros?aw, Lekston Andrzej, Kurek Anna, Gierlotka Marek, Trzeciak Przemys?aw, Hawranek Micha?, Ostrowska Zofia, Wiczkowski Andrzej, Polo?ski Lech, G?sior Mariu |
| Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Aug . Bhaskari J, Premalata C S, Shilpa V, Rahul B, Pallavi V R, Ramesh G, Krishnamoorthy Laksh |
| Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases. Cancer 2015 Jun 121 (11): 1898-905. Stremitzer Stefan, Zhang Wu, Yang Dongyun, Ning Yan, Stintzing Sebastian, Sebio Ana, Sunakawa Yu, Yamauchi Shinichi, Matsusaka Satoshi, El-Khoueiry Rita, Stift Judith, Wrba Friedrich, Gruenberger Thomas, Lenz Heinz-Jos |
| Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma. PloS one 2015 10 (12): e0145410. Yang Shu-Mei, Huang Chao-Yuan, Shiue Horng-Sheng, Huang Shu-Pin, Pu Yeong-Shiau, Chen Wei-Jen, Lin Ying-Chin, Hsueh Yu-M |
| Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2014 Apr 190 (4): 364-9. Langsenlehner T, Thurner E-M, Renner W, Gerger A, Kapp K S, Langsenlehner |
| Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia. Ophthalmology 2014 Jan 121 (1): 225-33. Miyake Masahiro, Yamashiro Kenji, Akagi-Kurashige Yumiko, Kumagai Kyoko, Nakata Isao, Nakanishi Hideo, Oishi Akio, Tsujikawa Akitaka, Yamada Ryo, Matsuda Fumihiko, Yoshimura Nagahi |
| A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Molecular carcinogenesis 2013 Nov 52 Suppl 1 E96-102. Absenger Gudrun, Szkandera Joanna, Stotz Michael, Pichler Martin, Winder Thomas, Langsenlehner Tanja, Langsenlehner Uwe, Samonigg Hellmut, Renner Wilfried, Gerger Arm |
| Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases. Annals of surgical oncology 2013 Jun . Shimomura M, Hinoi T, Kuroda S, Adachi T, Kawaguchi Y, Sasada T, Takakura Y, Egi H, Okajima M, Tashiro H, Nishizaka T, Ohdan H |
| Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy. The pharmacogenomics journal 2013 Apr 13 (2): 173-80. Pohl A, El-Khoueiry A, Yang D, Zhang W, Lurje G, Ning Y, Winder T, Hu-Lieskoven S, Iqbal S, Danenberg K D, Kahn M, Teo J-L, Shriki J, Stebbing J, Lenz H |
| Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. The Lancet. Oncology 2013 Jan 14 (1): 81-7. Schutz Fabio A B, Pomerantz Mark M, Gray Kathryn P, Atkins Michael B, Rosenberg Jonathan E, Hirsch Michelle S, McDermott David F, Lampron Megan E, Lee Gwo-Shu Mary, Signoretti Sabina, Kantoff Philip W, Freedman Matthew L, Choueiri Toni |
| The vascular endothelial growth factor (VEGF) +405 G/C polymorphism and its relationship with recurrent implantation failure in women in an IVF programme with ICSI. Journal of assisted reproduction and genetics 2012 Oct . Boudjenah R, Molina-Gomes D, Wainer R, de Mazancourt P, Selva J, Vialard F |
| Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Sep 18 (17): 4526-37. Eng Lawson, Azad Abul Kalam, Habbous Steven, Pang Vincent, Xu Wei, Maitland-van der Zee Anke H, Savas Sevtap, Mackay Helen J, Amir Eitan, Liu Geoffr |
| Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population. Pharmacogenomics 2012 May 13 (7): 763-70. Kjaer-Frifeldt Sanne, Fredslund Rikke, Lindebjerg Jan, Hansen Torben Froestrup, Spindler Karen-Lise Garm, Jakobsen Anders, |
| Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. Cancer science 2012 Mar 103 (3): 561-8. Dong Guanglong, Guo Xu, Fu Xiaoying, Wan Shaogui, Zhou Feng, Myers Ronald E, Bao Guoqiang, Burkart Ashlie, Yang Hushan, Xing Jinlia |
| Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. PloS one 2012 7 (7): e38192. Scartozzi Mario, Loretelli Cristian, Galizia Eva, Mandolesi Alessandra, Pistelli Mirco, Bittoni Alessandro, Giampieri Riccardo, Faloppi Luca, Bianconi Maristella, Del Prete Michela, Bianchi Francesca, Belvederesi Laura, Bearzi Italo, Cascinu Stefa |
| Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma. Anticancer research 2011 Dec 31 (12): 12. Lv S, Teugels E, Sadones J, Quartier E, Huylebrouck M, DU Four S, LE Mercier M, DE Witte O, Salmon I, Michotte A, DE Grève J, Neyns B |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: